A Phase 2 trial of TT 12
Latest Information Update: 25 Sep 2018
Price :
$35 *
At a glance
- Drugs TT 12 (Primary)
- Indications Cervical cancer; Oropharyngeal cancer
- Focus Therapeutic Use
- 25 Sep 2018 New trial record
- 20 Sep 2018 According to a St. Jude Childrens Research Hospital media release this trial is expected to begin in 2019.